| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0966-3274(03)00047-9 |
| P698 | PubMed publication ID | 12967781 |
| P50 | author | Milica Vukmanovic-Stejic | Q46152514 |
| Leonie S. Taams | Q55277361 | ||
| P2093 | author name string | Mike Salmon | |
| Milica Vukmanovic-Stejic | |||
| Arne Akbar | |||
| P2860 | cites work | Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation | Q24676080 |
| Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
| B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes | Q28143530 | ||
| Multiple immuno-regulatory defects in type-1 diabetes | Q28344695 | ||
| CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production | Q29619536 | ||
| Regulatory T cells in autoimmmunity*. | Q33904108 | ||
| Regulatory T cells: key controllers of immunologic self-tolerance | Q33941140 | ||
| Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro | Q33942128 | ||
| Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
| CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
| Regulatory T cells in the control of immune pathology. | Q34348983 | ||
| Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
| Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. | Q34516841 | ||
| Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta | Q34517421 | ||
| Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. | Q34518941 | ||
| CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease | Q34525987 | ||
| Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. | Q34529123 | ||
| Inhibition of human CD4(+)CD25(+high) regulatory T cell function | Q34529239 | ||
| Preferential recognition of self antigens despite normal thymic deletion of CD4(+)CD25(+) regulatory T cells | Q77584357 | ||
| Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals | Q77704341 | ||
| CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice | Q78022304 | ||
| The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
| Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy | Q78488897 | ||
| CD25+ immunoregulatory CD4 T cells mediate acquired central transplantation tolerance | Q78701766 | ||
| CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice | Q78701808 | ||
| Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells | Q78806915 | ||
| CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity | Q34529549 | ||
| Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide | Q34531452 | ||
| Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. III. Further characterization of the CD4+ suppressor cell and its mechanisms of action | Q36350238 | ||
| Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation | Q36367099 | ||
| Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells | Q36369536 | ||
| In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. | Q36370315 | ||
| CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness | Q36370807 | ||
| Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
| Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses | Q36376333 | ||
| Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen | Q40701079 | ||
| Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. | Q40801370 | ||
| Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific | Q40910998 | ||
| Anergic T cells as suppressor cells in vitro | Q41461549 | ||
| Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. | Q41907086 | ||
| Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells | Q41908906 | ||
| Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood | Q41973912 | ||
| Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood | Q41988688 | ||
| Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state | Q42466421 | ||
| TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation | Q42944002 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T cells | Q42947524 | ||
| A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood | Q46284741 | ||
| Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency | Q47992795 | ||
| Tracking the immunoregulatory mechanisms active during allograft tolerance | Q49022949 | ||
| Peptide specificity of thymic selection of CD4+CD25+ T cells. | Q51058071 | ||
| Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. | Q52011695 | ||
| Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance | Q56904417 | ||
| Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation | Q56904469 | ||
| CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses | Q56904642 | ||
| CD4(+)CD25(+) T cells facilitate the induction of T cell anergy | Q56904876 | ||
| Activation of CD25(+)CD4(+) regulatory T cells by oral antigen administration | Q56904883 | ||
| CD4+CD25high regulatory cells in human peripheral blood | Q56905059 | ||
| CD4 CD25 regulatory T cells are not functionally impaired in adult patients with IgE-mediated cow's milk allergy | Q61651905 | ||
| ‘Anergic’ T cells Modulate the T-cell Activating Capacity of Antigen-presenting Cells | Q61651911 | ||
| Anergic T cells actively suppress T cell responses via the antigen-presenting cell | Q61651916 | ||
| High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice | Q71641038 | ||
| CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10 | Q73509865 | ||
| CD4(+), CD25(+) T cells as regulators of alloimmune responses | Q73667423 | ||
| Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide | Q73688337 | ||
| Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population | Q73740429 | ||
| CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells | Q74012969 | ||
| Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation | Q74080415 | ||
| Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells | Q74244102 | ||
| Natural CD4 CD25(+) regulatory T cells control the burst of superantigen-induced cytokine production: the role of IL-10 | Q77542537 | ||
| P433 | issue | 3-4 | |
| P304 | page(s) | 277-285 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Immune regulation by CD4+CD25+ regulatory T cells: implications for transplantation tolerance | |
| P478 | volume | 11 |
| Q90704712 | Accumulation of High Levels of Monocytic Myeloid-Derived Suppressor Cells Enhances Graft Survival in Almost-Tolerant Kidney Transplant Recipients |
| Q54363666 | Antigen-specific T-regulatory cells can extend skin graft survival time in mice. |
| Q95642569 | Bone marrow dendritic cells deficient for CD40 and IL-23p19 are tolerogenic in vitro |
| Q51002465 | CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice. |
| Q84238174 | Chronic rejection of human kidney allografts |
| Q54419413 | Differentially modulated dendritic cells induce regulatory T cells with different characteristics. |
| Q35914958 | Induction of RNA interference in dendritic cells |
| Q33385541 | Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection |
| Q90734359 | Relationship of Transforming Growth Factor-βl and Arginase-1 Levels with Long-term Survival after Kidney Transplantation |
| Q34349909 | Role of CD4CD25FOXP3 Regulatory T Cells in Psoriasis |
| Q46894286 | The influence of immuosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation. |
Search more.